Discover the Future of Regenerative Medicine and Cell Therapy at the BioFab Investment Summit
Accelerating Commercialization | Connecting Capital | Building the BioIndustrial Future
The 2026 BioFab Investment Summit will bring together entrepreneurs, investors, commercialization experts, manufacturers, economic development leaders, and industry partners to accelerate the future of regenerative medicine and biotechnology.
This year's program will feature a Pitch Competition on Day 1 of the BioFab Investment Summit where emerging companies will have the opportunity to pitch their innovative products to a panel of judges. Participants will gain valuable feedback, increase visibility, and have the opportunity to compete for the first place prize: an exclusive investor-only dinner that evening at Westwind, hosted by ARMI's Founder, Executive Director & Chairman of the Board, Dean Kamen.
Whether you are building a startup, investing in transformative technologies, or supporting commercialization across the bioindustrial ecosystem, the BioFab Investment Summit provides meaningful connections and opportunities to engage with the next generation of biotechnology innovators.
